Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02732509 · ClinicalTrials.gov registry record
Chronic Inflammation and Exercise Responsiveness
A clinical trial of Metabolic Syndrome, sponsored by Mayo Clinic.
- Completed
- Registry status
- 146
- Enrollment target
- 1
- Study location
NCT02732509: Completed study of Metabolic Syndrome, sponsored by Mayo Clinic.
NCT02732509 is a study of Metabolic Syndrome that has completed, run by Mayo Clinic. The registered enrollment target is 146 participants, below the 1,204-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02732509, a study of Metabolic Syndrome, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 146 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine how chronic inflammation influences skeletal muscle protein metabolism and metabolic function in humans. The investigators will evaluate acute responsiveness to a single bout of exercise in men and women who are either lean or overweight/obese. The investigators will explore the relationship between circulating inflammatory markers and anabolic, proteomic, and transcriptional responses to acute exercise. The investigators will measure skeletal muscle protein synthesis in the postabsorptive state and in response to a single bout of exercise.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2016-03 |
| Est. Completion | 2021-12-31 |
What the finished NCT02732509 record still lists
NCT02732509 is an observational study that tracks outcomes without assigning an intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap, below the 1,204-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Metabolic Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT02732509 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT02732509 about?
NCT02732509 is a clinical study titled "Chronic Inflammation and Exercise Responsiveness". The purpose of this study is to determine how chronic inflammation influences skeletal muscle protein metabolism and metabolic function in humans. The investigators will evaluate acute responsiveness to a single bout of exercise in men and women who are either lean or overweight/obese. The investiga...
What is the current status of trial NCT02732509?
This trial is currently completed. The enrollment target is 146 participants. The study started on 2016-03. Estimated completion is 2021-12-31.
What conditions does trial NCT02732509 study?
This clinical trial studies the following conditions: Metabolic Syndrome.
Who is sponsoring clinical trial NCT02732509?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02732509 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolic Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02732509's enrollment target sits among peer trials
146 25th of 102 higher than 78 of 102 other Metabolic Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Metabolic Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Animal and Plant Proteins and Glucose Metabolism
RECRUITING · NA
-
Combined Oral Contraceptive Pill and Resistance Starch
RECRUITING · Phase 2
-
VR Stimulation of Exercise Response in Sedentary Humans
RECRUITING · NA
-
Impact of Supplemental Fiber on Gut and Vascular Health Related in Obesity Phenotypes
RECRUITING · NA
-
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03490929 · 146 participants · Phase 4
CEUS for Blunt Abdominal Trauma in Children
- NCT04755062 · 146 participants · NA
A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans
- NCT04867954 · 146 participants
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
- NCT05051618 · 146 participants · NA
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia